A Critical Discussion of the Rates of Progression and Causes of Optic Nerve Damage in Glaucoma: International Glaucoma Think Tank II: July 25-26, 2008, Florence, Italy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of glaucoma

• Publication date

  2009-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/IJG.0b013e3181aff461PMID 19680047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The functional consequences of glaucoma for eye-hand coordination.

  2009cited by this paper
• Terminology and guidelines for glaucoma

  2009cited by this paper
• Reprogramming progeny cells of embryonic RPE to produce photoreceptors: development of advanced photoreceptor traits under the induction of neuroD.

  2008cited by this paper
• A visual field index for calculation of glaucoma rate of progression.

  2008cited by this paper
• Practical recommendations for measuring rates of visual field change in glaucoma

  2008cited by this paper
• Progressive Ganglion Cell Degeneration Precedes Neuronal Loss in a Mouse Model of Glaucoma

  2008cited by this paper
• Socioeconomic position and hysterectomy: a cross-cohort comparison of women in Australia and Great Britain

  2008cited by this paper
• Evaluation of a System for Automatic Detection of Diabetic Retinopathy From Color Fundus Photographs in a Large Population of Patients With Diabetes

  2008cited by this paper
• Longitudinal profile of retinal ganglion cell damage after optic nerve crush with blue-light confocal scanning laser ophthalmoscopy.

  2008cited by this paper
• α2-Macroglobulin Is a Mediator of Retinal Ganglion Cell Death in Glaucoma*

  2008cited by this paper
• Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.

  2008cited by this paper
• Activation of autophagy in retinal ganglion cells

  2008cited by this paper
• Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia.

  2008cited by this paper
• Dendritic Pathology in the Superior Colliculus in a Rat Model of Experimental Glaucoma

  2008cited by this paper
• Systemic Blood Pressure Determines the Magnitude of IOP-Induced Blood Flow Change in the Optic Nerve Head of Non-Human Primate

  2008cited by this paper
• The importance of rates in glaucoma.

  2008cited by this paper
• Dendritic and synaptic protection: is it enough to save the retinal ganglion cell body and axon?

  2008cited by this paper
• Glaucoma and fitness to drive: using binocular visual fields to predict a milestone to blindness.

  2008cited by this paper
• Ocular blood flow on the move.

  2008cited by this paper
• Evaluation of a System for Automatic Detection of Diabetic Retinopathy From Color Fundus Photographs in a Large Population of Patients With Diabetes

  2008cited by this paper
• Neuroprotective and axon growth promoting effects of intraocular inflammation do not depend on oncomodulin or the presence of large numbers of activated macrophages.

  2008cited by this paper
• Risk factors for incident open-angle glaucoma: the Barbados Eye Studies.

  2008cited by this paper
• Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.

  2008cited by this paper
• Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants.

  2008cited by this paper
• A critical reevaluation of current glaucoma management: International Glaucoma Think Tank, July 27-29, 2006, Taormina, Sicily.

  2007cited by this paper
• The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation.

  2007cited by this paper
• The classical complement cascade mediates CNS synapse elimination.

  2007influential reference
• Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms.

  2007cited by this paper
• Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma

  2007cited by this paper
• Cost effectiveness and cost utility of an organized screening programme for glaucoma.

  2007cited by this paper
• Predictors of long-term progression in the early manifest glaucoma trial.

  2007cited by this paper
• Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.

  2007cited by this paper
• Astrocyte-derived CNTF switches mature RGCs to a regenerative state following inflammatory stimulation.

  2007cited by this paper
• Glaucoma is a neuronal disease

  2007cited by this paper
• Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy.

  2007cited by this paper
• Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study.

  2007cited by this paper
• What are the biomarkers for glaucoma?

  2007cited by this paper
• Automated segmentation of the optic disc from stereo color photographs using physiologically plausible features.

  2007cited by this paper
• Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain.

  2007cited by this paper
• Enhanced survival and regeneration of axotomized retinal neurons by repeated delivery of cell-permeable C3-like Rho antagonists.

  2007cited by this paper
• Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma.

  2007cited by this paper
• Quantification of Neuroretinal Rim Loss Using Digital Planimetry in Long-term Follow-up of Normals and Patients With Ocular Hypertension

  2007cited by this paper
• Retinotopic organization of primary visual cortex in glaucoma: Comparing fMRI measurements of cortical function with visual field loss.

  2007cited by this paper
• Alteration of retinal intrinsic survival signal and effect of alpha2-adrenergic receptor agonist in the retina of the chronic ocular hypertension rat.

  2007cited by this paper
• LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States.

  2007cited by this paper
• Sensorineural hearing loss in pseudoexfoliation syndrome.

  2007cited by this paper
• Assessment of Function Related to Vision (AFREV)

  2006cited by this paper
• Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin

  2006cited by this paper
• Visual field defects and retinal ganglion cell losses in patients with glaucoma.

  2006cited by this paper
• Retinal synthesis and deposition of complement components induced by ocular hypertension.

  2006cited by this paper
• Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex

  2006cited by this paper
• Retinal glial cell responses and Fas/FasL activation in rats with chronic ocular hypertension.

  2006cited by this paper
• Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma.

  2006cited by this paper
• Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells

  2006cited by this paper
• Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial

  2006cited by this paper
• Mitochondrial abnormalities in patients with primary open-angle glaucoma.

  2006cited by this paper
• Development and validation of a prognostic index for 4-year mortality in older adults.

  2006cited by this paper
• Optic disc and visual field progression in ocular hypertensive subjects: detection rates, specificity, and agreement.

  2006cited by this paper
• Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine.

  2005cited by this paper
• The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.

  2005cited by this paper
• Integrated visual fields: a new approach to measuring the binocular field of view and visual disability

  2005cited by this paper
• Comparison of methods to predict visual field progression in glaucoma.

  2005cited by this paper
• Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma.

  2005cited by this paper
• Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study.

  2005cited by this paper
• Longitudinal changes in the visual field and optic disc in glaucoma.

  2005cited by this paper
• Counteracting the Nogo Receptor Enhances Optic Nerve Regeneration If Retinal Ganglion Cells Are in an Active Growth State

  2004cited by this paper
• Some famous persons with visual problems as shown on postage stamps

  2004cited by this paper
• Optic disk appearance in advanced age-related macular degeneration.

  2004cited by this paper
• An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma.

  2004cited by this paper
• Risk assessment in the management of patients with ocular hypertension.

  2004cited by this paper
• Caspase-independent component of retinal ganglion cell death, in vitro.

  2004cited by this paper
• Transient ischemia of the retina results in massive degeneration of the retinotectal projection: long-term neuroprotection with brimonidine.

  2003cited by this paper
• The molecular basis of neural regeneration.

  2003cited by this paper
• Fibroblast growth factor-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury.

  2003cited by this paper
• The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.

  2003cited by this paper
• Measuring visual field progression in the Early Manifest Glaucoma Trial.

  2003cited by this paper
• The Finnish evidence-based guideline for open-angle glaucoma.

  2003cited by this paper
• A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection.

  2003cited by this paper
• Frequency of testing for detecting visual field progression

  2002cited by this paper
• Five-year incidence of open-angle glaucoma: the visual impairment project.

  2002cited by this paper
• Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth

  2002cited by this paper
• A comparison of glaucoma patients identified through mass screening and in routine clinical practice.

  2002cited by this paper
• The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

  2002cited by this paper
• Transient ischemia of the retina results in altered retrograde axoplasmic transport: neuroprotection with brimonidine.

  2002cited by this paper
• Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study.

  2002cited by this paper
• Amacrine-Signaled Loss of Intrinsic Axon Growth Ability by Retinal Ganglion Cells

  2002cited by this paper
• Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death.

  2001cited by this paper
• Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma.

  2001cited by this paper
• α2-Adrenoceptor Agonists Inhibit Vitreal Glutamate and Aspartate Accumulation and Preserve Retinal Function after Transient Ischemia

  2001cited by this paper
• Induction of heat shock protein 72 protects retinal ganglion cells in a rat glaucoma model.

  2001influential reference
• Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.

  2001cited by this paper
• The blood supply of the optic nerve head and the evaluation of it - myth and reality.

  2001cited by this paper
• Neuroprotective effect of α2 agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure

  2001cited by this paper
• Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons.

  2000cited by this paper
• Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein

  2000cited by this paper
• Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1

  2000cited by this paper
• Age related compliance of the lamina cribrosa in human eyes

  2000cited by this paper
• The optic nerve head in glaucoma: role of astrocytes in tissue remodeling.

  2000cited by this paper
• Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma.

  2000cited by this paper
• Lens Injury Stimulates Axon Regeneration in the Mature Rat Optic Nerve

  2000cited by this paper

• Glaucoma Suspects: The Impact of Risk Factor-Driven Review Periods on Clinical Load, Diagnoses, and Healthcare Costs

  2022cites this paper
• Effect of systemic blood pressure on optical coherence tomography angiography in glaucoma patients

  2020cites this paper
• Optic Nerve Traction During Adduction in Open Angle Glaucoma with Normal versus Elevated Intraocular Pressure

  2020cites this paper
• Intraocular pressure reduction in glaucoma: Does every mmHg count?

  2020cites this paper
• Magnetic Resonance Imaging of Optic Nerve Traction During Adduction in Primary Open-Angle Glaucoma With Normal Intraocular Pressure

  2017cites this paper
• Ocular Blood Flow Autoregulation Mechanisms and Methods

  2015cites this paper
• Concepto de sospecha de glaucoma de ángulo abierto: definición, diagnóstico y tratamiento

  2014cites this paper
• Neuroprotection in glaucoma: current and emerging approaches

  2014cites this paper
• The East London glaucoma prediction score: web-based validation of glaucoma risk screening tool.

  2013cites this paper
• Challenges in the development of glaucoma neuroprotection therapy

  2013influential citation
• Clinical trials for glaucoma neuroprotection are not impossible

  2012cites this paper
• The development of dynamic noise perimetry

  2010cites this paper